149 related articles for article (PubMed ID: 35111497)
1. Molecular-targeted therapy for advanced anaplastic thyroid cancer combined with nutritional support.
Maegawa Y; Higashiguchi T; Futamura A; Tsuzuki N; Murai M
Fujita Med J; 2019; 5(1):25-29. PubMed ID: 35111497
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.
Yamazaki H; Iwasaki H; Suganuma N; Toda S; Masudo K; Nakayama H; Rino Y; Masuda M
Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31600721
[TBL] [Abstract][Full Text] [Related]
3. Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report.
Yamazaki H; Masudo K; Kanada S; Inayama Y; Hayashi H; Fujii Y; Rino Y
Surg Case Rep; 2023 Mar; 9(1):38. PubMed ID: 36920674
[TBL] [Abstract][Full Text] [Related]
4. Nasogastric administration of lenvatinib solution in a mechanically ventilated patient with rapidly growing anaplastic thyroid cancer.
Kawano F; Yonekawa T; Yamaguchi H; Shibata N; Tashiro K; Ikenoue M; Munakata S; Higuchi K; Tanaka H; Sato Y; Hosokawa A; Takeno S; Nakamura K; Nanashima A
Endocrinol Diabetes Metab Case Rep; 2020 Aug; 2020():. PubMed ID: 32755964
[TBL] [Abstract][Full Text] [Related]
5. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
6. Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Dierks C; Seufert J; Aumann K; Ruf J; Klein C; Kiefer S; Rassner M; Boerries M; Zielke A; la Rosee P; Meyer PT; Kroiss M; Weißenberger C; Schumacher T; Metzger P; Weiss H; Smaxwil C; Laubner K; Duyster J; von Bubnoff N; Miething C; Thomusch O
Thyroid; 2021 Jul; 31(7):1076-1085. PubMed ID: 33509020
[No Abstract] [Full Text] [Related]
7. A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib.
Hamamoto T; Kono T; Taruya T; Ishino T; Ueda T; Takeno S
Auris Nasus Larynx; 2022 Jun; 49(3):515-519. PubMed ID: 33109426
[TBL] [Abstract][Full Text] [Related]
8. Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer.
Su X; Liu J; Zhang H; Gu Q; Zhou X; Ji M; Yao D
Onco Targets Ther; 2020; 13():11183-11192. PubMed ID: 33173310
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Thyroid Carcinoma Treated with Lenvatinib.
Ohkubo JI; Takahashi A; Ikezaki S; Takenaga F; Ohkubo Y; Suzuki H
Kurume Med J; 2018 Feb; 64(1.2):29-33. PubMed ID: 29057760
[TBL] [Abstract][Full Text] [Related]
10. Lenvatinib for Anaplastic Thyroid Cancer.
Tahara M; Kiyota N; Yamazaki T; Chayahara N; Nakano K; Inagaki L; Toda K; Enokida T; Minami H; Imamura Y; Sasaki T; Suzuki T; Fujino K; Dutcus CE; Takahashi S
Front Oncol; 2017; 7():25. PubMed ID: 28299283
[TBL] [Abstract][Full Text] [Related]
11. Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.
Gunda V; Gigliotti B; Ashry T; Ndishabandi D; McCarthy M; Zhou Z; Amin S; Lee KE; Stork T; Wirth L; Freeman GJ; Alessandrini A; Parangi S
Int J Cancer; 2019 May; 144(9):2266-2278. PubMed ID: 30515783
[TBL] [Abstract][Full Text] [Related]
12. Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer.
Kim M; Ahn J; Song DE; Yoon JH; Kang HC; Lim DJ; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim BH
Endocrine; 2021 Feb; 71(2):427-433. PubMed ID: 32729092
[TBL] [Abstract][Full Text] [Related]
13. Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer.
Iwasaki H; Toda S; Suganuma N; Murayama D; Nakayama H; Masudo K
Mol Clin Oncol; 2020 Feb; 12(2):138-143. PubMed ID: 31929884
[TBL] [Abstract][Full Text] [Related]
14. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
Iesato A; Li S; Sadow PM; Abbasian M; Nazarian A; Lawler J; Nucera C
Thyroid; 2023 Jul; 33(7):835-848. PubMed ID: 37171127
[No Abstract] [Full Text] [Related]
15. Lenvatinib for Anaplastic Thyroid Cancer and Lenvatinib-Induced Thyroid Dysfunction.
Koyama S; Miyake N; Fujiwara K; Morisaki T; Fukuhara T; Kitano H; Takeuchi H
Eur Thyroid J; 2018 Jun; 7(3):139-144. PubMed ID: 30023346
[TBL] [Abstract][Full Text] [Related]
16. Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview.
Sparano C; Godbert Y; Attard M; Do Cao C; Zerdoud S; Roudaut N; Joly C; Berdelou A; Hadoux J; Lamartina L; Schlumberger M; Leboulleux S
Endocr Relat Cancer; 2021 Jan; 28(1):15-26. PubMed ID: 33112817
[TBL] [Abstract][Full Text] [Related]
17. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
[TBL] [Abstract][Full Text] [Related]
18. Common carotid artery rupture during treatment with lenvatinib for anaplastic thyroid cancer.
Obata K; Sugitani I; Ebina A; Sugiura Y; Toda K; Takahashi S; Kawabata K
Int Cancer Conf J; 2016 Oct; 5(4):197-201. PubMed ID: 31149454
[TBL] [Abstract][Full Text] [Related]
19. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer.
Yamazaki H; Yokose T; Hayashi H; Iwasaki H; Osanai S; Suganuma N; Nakayama H; Masudo K; Rino Y; Masuda M
Cancer Chemother Pharmacol; 2018 Oct; 82(4):649-654. PubMed ID: 30051190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
